• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脑胶质瘤干细胞的侵袭潜能升高。

Elevated invasive potential of glioblastoma stem cells.

机构信息

Center for Experimental Research, The First People's Hospital, Shanghai Jiao Tong University, Shanghai, China.

出版信息

Biochem Biophys Res Commun. 2011 Mar 25;406(4):643-8. doi: 10.1016/j.bbrc.2011.02.123. Epub 2011 Mar 1.

DOI:10.1016/j.bbrc.2011.02.123
PMID:21371437
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3065536/
Abstract

Glioblastomas (GBMs) are the most lethal and common types of primary brain tumors. The hallmark of GBMs is their highly infiltrative nature. The cellular and molecular mechanisms underlying the aggressive cancer invasion in GBMs are poorly understood. GBM displays remarkable cellular heterogeneity and hierarchy containing self-renewing glioblastoma stem cells (GSCs). Whether GSCs are more invasive than non-stem tumor cells and contribute to the invasive phenotype in GBMs has not been determined. Here we provide experimental evidence supporting that GSCs derived from GBM surgical specimens or xenografts display greater invasive potential in vitro and in vivo than matched non-stem tumor cells. Furthermore, we identified several invasion-associated proteins that were differentially expressed in GSCs relative to non-stem tumor cells. One of such proteins is L1CAM, a cell surface molecule shown to be critical to maintain GSC tumorigenic potential in our previous study. Immunohistochemical staining showed that L1CAM is highly expressed in a population of cancer cells in the invasive fronts of primary GBMs. Collectively, these data demonstrate the invasive nature of GSCs, suggesting that disrupting GSCs through a specific target such as L1CAM may reduce GBM cancer invasion and tumor recurrence.

摘要

胶质母细胞瘤(GBM)是最致命和最常见的原发性脑肿瘤。GBM 的标志是其高度浸润性。GBM 中侵袭性癌症侵袭的细胞和分子机制尚未完全了解。GBM 表现出明显的细胞异质性和层次结构,包含自我更新的胶质母细胞瘤干细胞(GSCs)。GSCs 是否比非干细胞肿瘤细胞更具侵袭性,并有助于 GBM 中的侵袭表型尚未确定。在这里,我们提供了实验证据,支持源自 GBM 手术标本或异种移植物的 GSCs 在体外和体内比匹配的非干细胞肿瘤细胞具有更大的侵袭潜力。此外,我们鉴定了一些在 GSCs 中相对于非干细胞肿瘤细胞差异表达的侵袭相关蛋白。其中一种蛋白是 L1CAM,是我们之前的研究中表明对维持 GSC 肿瘤发生潜能至关重要的细胞表面分子。免疫组织化学染色显示,L1CAM 在原发性 GBM 侵袭前沿的一群癌细胞中高度表达。总之,这些数据表明 GSCs 具有侵袭性,表明通过 L1CAM 等特定靶标破坏 GSCs 可能会降低 GBM 癌症侵袭和肿瘤复发的风险。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de58/3065536/3b7c4b9a7134/nihms278209f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de58/3065536/e2427ec68082/nihms278209f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de58/3065536/5251eeabd1ef/nihms278209f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de58/3065536/e861e0434dd5/nihms278209f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de58/3065536/3b7c4b9a7134/nihms278209f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de58/3065536/e2427ec68082/nihms278209f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de58/3065536/5251eeabd1ef/nihms278209f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de58/3065536/e861e0434dd5/nihms278209f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de58/3065536/3b7c4b9a7134/nihms278209f4.jpg

相似文献

1
Elevated invasive potential of glioblastoma stem cells.脑胶质瘤干细胞的侵袭潜能升高。
Biochem Biophys Res Commun. 2011 Mar 25;406(4):643-8. doi: 10.1016/j.bbrc.2011.02.123. Epub 2011 Mar 1.
2
Targeting role of glioma stem cells for glioblastoma multiforme.针对多形性胶质母细胞瘤的神经胶质瘤干细胞靶向治疗。
Curr Med Chem. 2013;20(15):1974-84. doi: 10.2174/0929867311320150004.
3
Growth factor independence underpins a paroxysmal, aggressive Wnt5a/EphA2 phenotype in glioblastoma stem cells, conducive to experimental combinatorial therapy.生长因子独立性是胶质母细胞瘤干细胞中突发、侵袭性的 Wnt5a/EphA2 表型的基础,有利于实验性联合治疗。
J Exp Clin Cancer Res. 2022 Apr 12;41(1):139. doi: 10.1186/s13046-022-02333-1.
4
Maintenance of primary tumor phenotype and genotype in glioblastoma stem cells.在神经胶质瘤干细胞中维持原发性肿瘤表型和基因型。
Neuro Oncol. 2012 Feb;14(2):132-44. doi: 10.1093/neuonc/nor195. Epub 2011 Nov 7.
5
Cancer stem cells in glioblastoma--molecular signaling and therapeutic targeting.胶质母细胞瘤中的癌症干细胞——分子信号和治疗靶点。
Protein Cell. 2010 Jul;1(7):638-55. doi: 10.1007/s13238-010-0078-y. Epub 2010 Jul 29.
6
L1CAM regulates DNA damage checkpoint response of glioblastoma stem cells through NBS1.L1CAM 通过 NBS1 调节神经胶质瘤干细胞的 DNA 损伤检查点反应。
EMBO J. 2011 Mar 2;30(5):800-13. doi: 10.1038/emboj.2011.10. Epub 2011 Feb 4.
7
Molecular heterogeneity in a patient-derived glioblastoma xenoline is regulated by different cancer stem cell populations.患者来源的胶质母细胞瘤异种移植瘤中的分子异质性由不同的癌症干细胞群体调控。
PLoS One. 2015 May 8;10(5):e0125838. doi: 10.1371/journal.pone.0125838. eCollection 2015.
8
The LIM-only transcription factor LMO2 determines tumorigenic and angiogenic traits in glioma stem cells.仅含LIM结构域的转录因子LMO2决定了胶质瘤干细胞的致瘤性和血管生成特性。
Cell Death Differ. 2015 Sep;22(9):1517-25. doi: 10.1038/cdd.2015.7. Epub 2015 Feb 27.
9
The Importance of Tumor Stem Cells in Glioblastoma Resistance to Therapy.肿瘤干细胞在胶质母细胞瘤治疗耐药中的重要性
Int J Mol Sci. 2021 Apr 8;22(8):3863. doi: 10.3390/ijms22083863.
10
Arsenic trioxide disrupts glioma stem cells via promoting PML degradation to inhibit tumor growth.三氧化二砷通过促进早幼粒细胞白血病蛋白(PML)降解来破坏胶质瘤干细胞,从而抑制肿瘤生长。
Oncotarget. 2015 Nov 10;6(35):37300-15. doi: 10.18632/oncotarget.5836.

引用本文的文献

1
Stem cell-derived neural organoids as platforms to investigate glioblastoma invasion and migration: A systematic review.干细胞衍生的神经类器官作为研究胶质母细胞瘤侵袭和迁移的平台:一项系统综述
World J Stem Cells. 2025 Aug 26;17(8):108898. doi: 10.4252/wjsc.v17.i8.108898.
2
Transposable element dynamics in glioblastoma stem cells: insights from locus-specific quantification.胶质母细胞瘤干细胞中的转座元件动态:来自基因座特异性定量分析的见解
Mob DNA. 2025 Sep 2;16(1):33. doi: 10.1186/s13100-025-00370-z.
3
Takeaways from meta-analysis: indications of combinational treatments for glioblastoma.

本文引用的文献

1
L1CAM regulates DNA damage checkpoint response of glioblastoma stem cells through NBS1.L1CAM 通过 NBS1 调节神经胶质瘤干细胞的 DNA 损伤检查点反应。
EMBO J. 2011 Mar 2;30(5):800-13. doi: 10.1038/emboj.2011.10. Epub 2011 Feb 4.
2
Potential therapeutic implications of cancer stem cells in glioblastoma.脑胶质瘤中肿瘤干细胞的潜在治疗意义。
Biochem Pharmacol. 2010 Sep 1;80(5):654-65. doi: 10.1016/j.bcp.2010.04.035. Epub 2010 May 10.
3
Medical oncology: treatment and management of malignant gliomas.医学肿瘤学:恶性胶质瘤的治疗与管理
荟萃分析的要点:胶质母细胞瘤联合治疗的指征
J Neurooncol. 2025 Aug 21. doi: 10.1007/s11060-025-05205-8.
4
Natural Compounds That Target Glioma Stem Cells.靶向胶质瘤干细胞的天然化合物。
NeuroSci. 2025 Jun 5;6(2):52. doi: 10.3390/neurosci6020052.
5
Metabolic regulation of the glioblastoma stem cell epitranscriptome by malate dehydrogenase 2.通过苹果酸脱氢酶 2 对神经胶质瘤干细胞转录组的代谢调控。
Cell Metab. 2024 Nov 5;36(11):2419-2436.e8. doi: 10.1016/j.cmet.2024.09.014. Epub 2024 Oct 24.
6
Targeting glioblastoma with a brain-penetrant drug that impairs brain tumor stem cells via NLE1-Notch1 complex.用一种穿透血脑屏障的药物靶向治疗神经胶质瘤,该药物通过 NLE1-Notch1 复合物来损伤脑肿瘤干细胞。
Stem Cell Reports. 2024 Nov 12;19(11):1534-1547. doi: 10.1016/j.stemcr.2024.09.007. Epub 2024 Oct 17.
7
Glioma Stem Cells as Promoter of Glioma Progression: A Systematic Review of Molecular Pathways and Targeted Therapies.神经胶质瘤干细胞促进神经胶质瘤进展:分子途径和靶向治疗的系统评价。
Int J Mol Sci. 2024 Jul 22;25(14):7979. doi: 10.3390/ijms25147979.
8
The role of lactate-induced protein lactylation in gliomas: implications for preclinical research and the development of new treatments.乳酸诱导的蛋白质乳酰化在胶质瘤中的作用:对临床前研究和新疗法开发的启示
Front Pharmacol. 2024 Jun 25;15:1383274. doi: 10.3389/fphar.2024.1383274. eCollection 2024.
9
Dissecting TGF-β-induced glioblastoma invasion with engineered hyaluronic acid hydrogels.利用工程化透明质酸水凝胶剖析转化生长因子-β诱导的胶质母细胞瘤侵袭
APL Bioeng. 2024 Jun 13;8(2):026125. doi: 10.1063/5.0203213. eCollection 2024 Jun.
10
Glioblastoma modeling with 3D organoids: progress and challenges.利用三维类器官进行胶质母细胞瘤建模:进展与挑战
Oxf Open Neurosci. 2023 Jul 6;2:kvad008. doi: 10.1093/oons/kvad008. eCollection 2023.
Nat Rev Clin Oncol. 2010 Feb;7(2):75-7. doi: 10.1038/nrclinonc.2009.221.
4
The cleavage of semaphorin 3C induced by ADAMTS1 promotes cell migration.ADAMTS1 诱导神经信号蛋白 3C 裂解促进细胞迁移。
J Biol Chem. 2010 Jan 22;285(4):2463-73. doi: 10.1074/jbc.M109.055129. Epub 2009 Nov 13.
5
Glioma tumor stem-like cells promote tumor angiogenesis and vasculogenesis via vascular endothelial growth factor and stromal-derived factor 1.胶质瘤肿瘤干细胞样细胞通过血管内皮生长因子和基质细胞衍生因子1促进肿瘤血管生成和血管发生。
Cancer Res. 2009 Sep 15;69(18):7243-51. doi: 10.1158/0008-5472.CAN-09-0167. Epub 2009 Sep 8.
6
Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells.缺氧诱导因子调节胶质瘤干细胞的致瘤能力。
Cancer Cell. 2009 Jun 2;15(6):501-13. doi: 10.1016/j.ccr.2009.03.018.
7
microRNA-146b inhibits glioma cell migration and invasion by targeting MMPs.微小RNA-146b通过靶向基质金属蛋白酶抑制胶质瘤细胞的迁移和侵袭。
Brain Res. 2009 May 7;1269:158-65. doi: 10.1016/j.brainres.2009.02.037. Epub 2009 Mar 3.
8
PTEN/PI3K/Akt pathway regulates the side population phenotype and ABCG2 activity in glioma tumor stem-like cells.PTEN/PI3K/Akt信号通路调控胶质瘤肿瘤干细胞样细胞的侧群表型及ABCG2活性。
Cell Stem Cell. 2009 Mar 6;4(3):226-35. doi: 10.1016/j.stem.2009.01.007.
9
L1 cell adhesion molecule (L1CAM) in invasive tumors.侵袭性肿瘤中的L1细胞粘附分子(L1CAM)
Cancer Lett. 2009 Sep 18;282(2):137-45. doi: 10.1016/j.canlet.2008.12.021. Epub 2009 Jan 13.
10
alpha5-integrin is crucial for L1CAM-mediated chemoresistance in pancreatic adenocarcinoma.α5整合素对胰腺腺癌中L1CAM介导的化疗耐药性至关重要。
Int J Oncol. 2009 Jan;34(1):243-53.